Skip to main content

Table 3 Total infected cases, decompensated cirrhosis, HCC and liver-related deaths in Turkey, by scenario, 2015 and 2030

From: A micro-elimination approach to addressing hepatitis C in Turkey

Total viremic infections
 Increased treatment278,000142,000
 WHO targets278,00052,000
Prevalent Decompensated cirrhosis
 Increased treatment1500700
 WHO targets1500290
Prevalent Hepatocellular carcinoma
 Increased treatment990320
 WHO targets990170
Liver-related deaths
 Increased treatment1000530
 WHO targets1000200